Lisa Graf
{pods_people_role}
Lisa Graf is the Director of Clinical Projects at Redenlab, where she leads the planning and [...]
Solutions
Redenlab's Overview
Redenlab is a neuroscience clinical outcome assessment technology company founded in 2017. We specialise in the development and application of speech, language, swallowing, and audio biomarkers for clinical trials and healthcare research. Our proven digital speech platform delivers objective measurements of communication and other quality of life abilities, supporting the evaluation of treatment efficacy and ongoing patient health monitoring. Over a decade, we have partnered with a diverse range of clients, including leading pharmaceutical and biotech companies, medical clinics, and academic research institutions, solidifying our reputation as a trusted innovator in the field.
1. Clinically rigorous
We engage directly with key opinion leaders, clinics, and clinicians around the world to ensure our work is current and rooted in clinical practice. Combining our own clinical experience, extensive research record of accomplishment, and innovative products, we are leaders in the field.
2. Collaborative
Our flexible approach to working with partners fosters long term relationships, including collaborations with not-for-profit organisations, research groups and regulators to enhance our capabilities.
3. Pioneering
As the first to market in this space, we remain at the forefront of innovation, shaping the direction of outcome development and setting benchmarks for the industry.
4. Patient centric
Our focus is always on patients. By actively listening to consumers and patient advocacy groups and addressing their interests and concerns related to their disease profiles, we consistently prioritise their needs, setting us apart from competitors.
Our Team
Working with a global team of over 30 specialised staff, our leadership brings deep expertise in neuroscience, technology, and healthcare, driving innovation in clinical outcome assessment.
Thayabaran Kathiresan
{pods_people_role}
Thayabaran currently serves as the Director of Speech Analytics at Redenlab. In this role, Thaya drives [...]
Paul Maruff
{pods_people_role}
Dr. Paul Maruff, previously a member of our advisory board, has joined the Redenlab management team [...]
Geoff Stuart
{pods_people_role}
Dr Geoff Stuart PHD is Redenlab’s lead Statistician, supervising clinical trial statistics and data analytics. He [...]
Devon Borysiewicz
{pods_people_role}
Devon is Vice President of Technology and Software Engineering at Redenlab. Introduced to the technology sector [...]
Gloria Macan
{pods_people_role}
Gloria Macan is the Director of Marketing and Communications at Redenlab, where she brings a wealth [...]
Adam Vogel
{pods_people_role}
Adam Vogel PhD is the Chief Science Officer and Founder of Redenlab. He currently serves as [...]
Advisory Board
Our advisory board includes experts in neuroscience, technology, healthcare, legal, and finance. Their guidance helps us drive innovation in speech assessment, ensuring we deliver innovative solutions for clinical trials and patient care worldwide.
Lisa Graf
{pods_people_role}
Lisa Graf is the Director of Clinical Projects at Redenlab, where she leads the planning and [...]
Thayabaran Kathiresan
{pods_people_role}
Thayabaran currently serves as the Director of Speech Analytics at Redenlab. In this role, Thaya drives [...]
Paul Maruff
{pods_people_role}
Dr. Paul Maruff, previously a member of our advisory board, has joined the Redenlab management team [...]
Geoff Stuart
{pods_people_role}
Dr Geoff Stuart PHD is Redenlab’s lead Statistician, supervising clinical trial statistics and data analytics. He [...]
Devon Borysiewicz
{pods_people_role}
Devon is Vice President of Technology and Software Engineering at Redenlab. Introduced to the technology sector [...]
Gloria Macan
{pods_people_role}
Gloria Macan is the Director of Marketing and Communications at Redenlab, where she brings a wealth [...]
Adam Vogel
{pods_people_role}
Adam Vogel PhD is the Chief Science Officer and Founder of Redenlab. He currently serves as [...]
Transforming care: Redenlab's commitment to patients and innovation
Redenlab continues to set the benchmark of innovative clinical assessment in drug discovery and research pipelines. We are dedicated to delivering exceptional benefits to patients and sponsors by measuring what truly matters. Through a blend of world leading research, pioneering solutions, and a collaborative mind-set, we actively engage with patients and partners alike to shape the future of clinical trials. From addressing individual needs with empathy to setting industry standards in technology development, our mission is to transform care through meaningful measurement.
Your Partner in Clinical Excellence
We collaborate with CROs, sponsors, and clinical teams to deliver validated tools and insights tailored to your clinical trial needs.
